These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31364554)

  • 21. The Changing Epidemiology of Meningococcal Disease.
    Cohn A; MacNeil J
    Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.
    Hitchings MDT; Coldiron ME; Grais RF; Lipsitch M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007077. PubMed ID: 30856166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.
    Jaca A; Wiyeh AB; Sambala EZ; Wiysonge CS
    Pan Afr Med J; 2021; 39():57. PubMed ID: 34422180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningococcal carriage by age: a systematic review and meta-analysis.
    Christensen H; May M; Bowen L; Hickman M; Trotter CL
    Lancet Infect Dis; 2010 Dec; 10(12):853-61. PubMed ID: 21075057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt.
    Karachaliou A; Conlan AJ; Preziosi MP; Trotter CL
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S594-600. PubMed ID: 26553693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt.
    Mueller JE; Gessner BD
    Int J Infect Dis; 2010 Jul; 14(7):e553-9. PubMed ID: 20018546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.
    Balmer P; Burman C; Serra L; York LJ
    Hum Vaccin Immunother; 2018 May; 14(5):1118-1130. PubMed ID: 29565712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routinely vaccinating adolescents against meningococcus: targeting transmission & disease.
    Vetter V; Baxter R; Denizer G; Sáfadi MA; Silfverdal SA; Vyse A; Borrow R
    Expert Rev Vaccines; 2016 May; 15(5):641-58. PubMed ID: 26651380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemic meningitis control in countries of the African meningitis belt, 2016.
    Wkly Epidemiol Rec; 2017 Mar; 92(13):145-54. PubMed ID: 28361528
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
    Kristiansen PA; Diomandé F; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Kandolo D; Aké F; Saga IM; Clark TA; Misegades L; Martin SW; Thomas JD; Tiendrebeogo SR; Hassan-King M; Djingarey MH; Messonnier NE; Préziosi MP; Laforce FM; Caugant DA
    Clin Infect Dis; 2013 Feb; 56(3):354-63. PubMed ID: 23087396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rise in Group W Meningococcal Carriage in University Students, United Kingdom.
    Oldfield NJ; Cayrou C; AlJannat MAK; Al-Rubaiawi AAA; Green LR; Dada S; Steels OD; Stirrup C; Wanford J; Atwah BAY; Bayliss CD; Turner DPJ
    Emerg Infect Dis; 2017 Jun; 23(6):1009-1011. PubMed ID: 28518025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasopharyngeal carriage of Neisseria meningitidis in general population and meningococcal disease.
    Ichhpujani RL; Mohan R; Grover SS; Joshi PR; Kumari S
    J Commun Dis; 1990 Dec; 22(4):264-8. PubMed ID: 2129123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for acquisition of meningococcal carriage in the African meningitis belt.
    Cooper LV; Robson A; Trotter CL; Aseffa A; Collard JM; Daugla DM; Diallo A; Hodgson A; Jusot JF; Omotara B; Sow S; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Chandramohan D; Borrow R; Maiden MCJ; Greenwood B; Stuart JM;
    Trop Med Int Health; 2019 Apr; 24(4):392-400. PubMed ID: 30729627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.
    Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG
    PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-meningococcal vaccines: diversity of vaccination policies and recommendations].
    Gendrel D
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S70-6. PubMed ID: 22883370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
    Mohammed I; Iliyasu G; Habib AG
    Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningitis control in countries of the African meningitis belt, 2015.
    Wkly Epidemiol Rec; 2016 Apr; 91(16):209-16. PubMed ID: 27108455
    [No Abstract]   [Full Text] [Related]  

  • 40. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.